essential tremor

Praxis moves ahead despite phase 3 tremor trial futility finding

Weeks after Praxis CEO said the chances of futility were “less than 3%,” an interim analysis found the study is unlikely to meet its primary endpoint.

Nick Paul Taylor Feb 28, 2025 9:11am

Elderly patient old old age alzheimers parkinsons assisted living hospice

Cala raises $50M to boost its wearable hand tremor therapy

Dec 9, 2024 10:58am

Brain and money connected by a thread on a white background

Acadia inks $582M biobucks pact for Danish biotech's neuro asset

Nov 26, 2024 5:00pm

Biogen cans SAGE-324 collaboration after essential tremor fail

Sep 26, 2024 9:00am

balloon missed target pop arrows miss failure

Biogen, Sage flunk midphase essential tremor trial, stop study

Jul 24, 2024 8:10am

Graphic showing arrows missing the bullseye on a target

Jazz's ph. 2 essential tremor test misses endpoint

Jun 20, 2024 9:30am